Entries by oslocancer

Fighting the pandemic of antimicrobial resistance

This is the first article in the new series Start-up Spotlight, which features the most promising start-ups from the Norwegian health clusters. AdjuTec Pharma is preparing the company’s First-in-Human phase I clinical trial. The Norwegian start-up company AdjuTec Pharma has developed a new antibiotic product in the fight against antimicrobial resistance (AMR), which is now […]